| Treatments | Returns and costs (USD) | Gross income | Total varying cost | Net income | Net income over control | MRR (%) | Dominance analysis (%) | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 |
| SD1 | F0 | 1,228 | 1,437 | 0.00 | 0.00 | 1,228 | 1,437 | — | — | — | — | — | — | F1 | 1,614 | 1,855 | 130.60 | 130.60 | 1,484 | 1,724 | 256 | 287 | 196.00 | 220.00 | 196 | 220 | F2 | 2,105 | 2,286 | 187.45 | 187.45 | 1,918 | 2,098 | 690 | 661 | 368.20 | 352.87 | 763.78 | 658.11 | F3 | 2,275 | 2,398 | 318.05 | 318.05 | 1,957 | 2,080 | 729 | 643 | 229.32 | 202.22 | 30 | −14d |
| SD2 | F0 | 1,283 | 1,324 | 0.00 | 0.00 | 1,283 | 1,324 | — | — | — | — | — | — | F1 | 1,659 | 1,789 | 130.60 | 130.60 | 1,528 | 1,659 | 246 | 334 | 188.00 | 256.00 | 188 | 256 | F2 | 1,972 | 2,210 | 187.45 | 187.45 | 1,785 | 2,022 | 502 | 698 | 267.87 | 372.38 | 451.35 | 639.73 | F3 | 2,105 | 2,225 | 287.32 | 287.32 | 1,818 | 1,938 | 535 | 614 | 186.36 | 213.64 | 33.38 | −84.31d |
| SD3 | F0 | 1,003 | 1,162 | 0.00 | 0.00 | 1,003 | 1,162 | — | — | — | — | — | — | F1 | 1,330 | 1,690 | 149.04 | 149.04 | 1,180 | 1,541 | 177 | 379 | 119.07 | 254.02 | 119.07 | 254.02 | F2 | 1,502 | 2,064 | 205.89 | 205.89 | 1,296 | 1,858 | 293 | 695 | 142.31 | 337.69 | 203.24 | 557.03 | F3 | 1,648 | 1,930 | 367.22 | 367.22 | 1,281 | 1,563 | 278 | 401 | 75.69 | 109.12 | −9.33d | −182.57d |
| SD4 | F0 | 784 | 718 | 0.00 | 0.00 | 784 | 718 | — | — | — | — | — | — | F1 | 1,178 | 912 | 149.04 | 149.04 | 1,029 | 763 | 245 | 44 | 164.64 | 29.69 | 164.64 | 29.69 | F2 | 1,228 | 1,081 | 224.33 | 258.13 | 1,003 | 823 | 220 | 105 | 97.95 | 40.65 | −34.08d | 55.63 | F3 | 1,246 | 1,118 | 336.49 | 336.49 | 909 | 781 | 126 | 63 | 37.40 | 18.77 | −83.70d | −53.33d |
|
|